These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36266286)

  • 21. Mouse Homolog of the Human
    Park JH; Li J; Starost MF; Liu C; Zhuang J; Chen J; Achatz MI; Kang JG; Wang PY; Savage SA; Hwang PM
    Cancer Res; 2018 Sep; 78(18):5375-5383. PubMed ID: 30042151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatic mutant clones colonize the human esophagus with age.
    Martincorena I; Fowler JC; Wabik A; Lawson ARJ; Abascal F; Hall MWJ; Cagan A; Murai K; Mahbubani K; Stratton MR; Fitzgerald RC; Handford PA; Campbell PJ; Saeb-Parsy K; Jones PH
    Science; 2018 Nov; 362(6417):911-917. PubMed ID: 30337457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53.
    Werness BA; Parvatiyar P; Ramus SJ; Whittemore AS; Garlinghouse-Jones K; Oakley-Girvan I; DiCioccio RA; Wiest J; Tsukada Y; Ponder BA; Piver MS
    J Natl Cancer Inst; 2000 Jul; 92(13):1088-91. PubMed ID: 10880552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation, clonal fitness and field change in epithelial carcinogenesis.
    Frede J; Adams DJ; Jones PH
    J Pathol; 2014 Nov; 234(3):296-301. PubMed ID: 25046364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of normal G1 checkpoint control is an early step in carcinogenesis, independent of p53 status.
    Syljuåsen RG; Krolewski B; Little JB
    Cancer Res; 1999 Mar; 59(5):1008-14. PubMed ID: 10070956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Irradiation induces p53 loss of heterozygosity in breast cancer expressing mutant p53.
    Ghaleb A; Yallowitz A; Marchenko N
    Commun Biol; 2019; 2():436. PubMed ID: 31799437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic.
    Kadosh E; Snir-Alkalay I; Venkatachalam A; May S; Lasry A; Elyada E; Zinger A; Shaham M; Vaalani G; Mernberger M; Stiewe T; Pikarsky E; Oren M; Ben-Neriah Y
    Nature; 2020 Oct; 586(7827):133-138. PubMed ID: 32728212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiparameter flow cytometry for simultaneous assessment of p53 protein expression and cellular DNA content in oral squamous cell carcinomas: evidence for the development of aneuploid clones from p53-deficient diploid progenitor cells.
    Hemmer J; Polackova J
    Int J Oncol; 2000 Nov; 17(5):933-7. PubMed ID: 11029495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic instability in mutant p53 cancer cells upon entotic engulfment.
    Mackay HL; Moore D; Hall C; Birkbak NJ; Jamal-Hanjani M; Karim SA; Phatak VM; Piñon L; Morton JP; Swanton C; Le Quesne J; Muller PAJ
    Nat Commun; 2018 Aug; 9(1):3070. PubMed ID: 30076358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation imbalance in single oesophageal progenitor cells causes clonal immortalization and field change.
    Alcolea MP; Greulich P; Wabik A; Frede J; Simons BD; Jones PH
    Nat Cell Biol; 2014 Jun; 16(6):615-22. PubMed ID: 24814514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonal dynamics following p53 loss of heterozygosity in Kras-driven cancers.
    Muzumdar MD; Dorans KJ; Chung KM; Robbins R; Tammela T; Gocheva V; Li CM; Jacks T
    Nat Commun; 2016 Sep; 7():12685. PubMed ID: 27585860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 mutation and loss have different effects on tumourigenesis in a novel mouse model of pleomorphic rhabdomyosarcoma.
    Doyle B; Morton JP; Delaney DW; Ridgway RA; Wilkins JA; Sansom OJ
    J Pathol; 2010 Oct; 222(2):129-37. PubMed ID: 20662002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromosomal instability associated with global DNA hypomethylation is associated with the initiation and progression of esophageal squamous cell carcinoma.
    Kawano H; Saeki H; Kitao H; Tsuda Y; Otsu H; Ando K; Ito S; Egashira A; Oki E; Morita M; Oda Y; Maehara Y
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S696-702. PubMed ID: 24898425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. UV-induced ablation of the epidermal basal layer including p53-mutant clones resets UV carcinogenesis showing squamous cell carcinomas to originate from interfollicular epidermis.
    Rebel HG; Bodmann CA; van de Glind GC; de Gruijl FR
    Carcinogenesis; 2012 Mar; 33(3):714-20. PubMed ID: 22227037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM.
    Song H; Hollstein M; Xu Y
    Nat Cell Biol; 2007 May; 9(5):573-80. PubMed ID: 17417627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preneoplastic lesion growth driven by the death of adjacent normal stem cells.
    Chao DL; Eck JT; Brash DE; Maley CC; Luebeck EG
    Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15034-9. PubMed ID: 18815380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of neoplastic cell lineages in Barrett oesophagus.
    Barrett MT; Sanchez CA; Prevo LJ; Wong DJ; Galipeau PC; Paulson TG; Rabinovitch PS; Reid BJ
    Nat Genet; 1999 May; 22(1):106-9. PubMed ID: 10319873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 mutation profiling of multiple esophageal carcinoma using laser capture microdissection to demonstrate field carcinogenesis.
    Ito S; Ohga T; Saeki H; Nakamura T; Watanabe M; Tanaka S; Kakeji Y; Maehara Y
    Int J Cancer; 2005 Jan; 113(1):22-8. PubMed ID: 15386362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo.
    Alexandrova EM; Mirza SA; Xu S; Schulz-Heddergott R; Marchenko ND; Moll UM
    Cell Death Dis; 2017 Mar; 8(3):e2661. PubMed ID: 28277540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.